Production (Stage)
enGene Holdings Inc.
ENGN
$3.33
$0.082.46%
NASDAQ
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 6.92M | 6.64M | 6.18M | 5.21M | 7.46M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 27.12M | 26.61M | 17.46M | 16.76M | 17.31M |
Operating Income | -27.12M | -26.61M | -17.46M | -16.76M | -17.31M |
Income Before Tax | -25.58M | -24.60M | -15.28M | -14.18M | -14.96M |
Income Tax Expenses | 240.00K | 18.00K | 19.00K | -29.00K | 21.00K |
Earnings from Continuing Operations | -25.82M | -24.62M | -15.30M | -14.15M | -14.98M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -25.82M | -24.62M | -15.30M | -14.15M | -14.98M |
EBIT | -27.12M | -26.61M | -17.46M | -16.76M | -17.31M |
EBITDA | -27.02M | -26.51M | -17.43M | -16.68M | -17.23M |
EPS Basic | -0.51 | -0.48 | -0.34 | -0.32 | -0.38 |
Normalized Basic EPS | -0.31 | -0.30 | -0.21 | -0.20 | -0.24 |
EPS Diluted | -0.51 | -0.48 | -0.34 | -0.32 | -0.38 |
Normalized Diluted EPS | -0.31 | -0.30 | -0.21 | -0.20 | -0.24 |
Average Basic Shares Outstanding | 51.02M | 50.98M | 44.44M | 44.17M | 39.44M |
Average Diluted Shares Outstanding | 51.02M | 50.98M | 44.44M | 44.17M | 39.44M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |